Patent classifications
C07D303/04
Epoxy compound, curable composition, cured product, method of producing epoxy compound, and reactive diluent
The present invention discloses a monoepoxy compound represented by the following Formula (1), a curable composition containing the same, a cured product therefrom, a method of producing the monoepoxy compound, and a reactive diluent containing the monoepoxy compound. The monoepoxy compound represented by the Formula (1) is useful in that it is capable of reducing the viscosity of a curable composition containing the monoepoxy compound, while preventing a reduction in the heat resistance of the curable composition as well as a reduction in the weight of the curable composition upon curing. ##STR00001##
(In the Formula (1), R.sup.1 to R.sup.6 are each independently selected from the group consisting of a hydrogen atom, an alkyl group, and an alkoxy group.)
Epoxy compound, curable composition, cured product, method of producing epoxy compound, and reactive diluent
The present invention discloses a monoepoxy compound represented by the following Formula (1), a curable composition containing the same, a cured product therefrom, a method of producing the monoepoxy compound, and a reactive diluent containing the monoepoxy compound. The monoepoxy compound represented by the Formula (1) is useful in that it is capable of reducing the viscosity of a curable composition containing the monoepoxy compound, while preventing a reduction in the heat resistance of the curable composition as well as a reduction in the weight of the curable composition upon curing. ##STR00001##
(In the Formula (1), R.sup.1 to R.sup.6 are each independently selected from the group consisting of a hydrogen atom, an alkyl group, and an alkoxy group.)
Modulators of Liver Receptor Homologue 1 (LRH-1) and Uses
This disclosure relates to modulators of liver receptor homologue 1 (LRH-1) and methods of managing disease and conditions related thereto. In certain embodiments, modulators are derivatives of hexahydropentalene. In certain embodiments, this disclosure relates to methods of treating or preventing cancer, diabetes, or cardiovascular disease by administering an effective amount of a hexahydropentalene derivative disclosed herein.
Alkynyl-containing compound additive for non-aqueous electrolyte solution, and non-aqueous electrolyte solution for lithium secondary battery and lithium secondary battery which include the same
The present invention relates to an additive for a non-aqueous electrolyte solution, which may suppress the generation of metallic foreign matter causing a side effect in a battery while forming a stable film on the surface of an electrode, a non-aqueous electrolyte solution for a lithium secondary battery which includes the additive, and a lithium secondary battery including the non-aqueous electrolyte solution.
TRANSITION METAL-BASED HETEROGENEOUS CARBONYLATION REACTION CATALYST AND METHOD FOR PREPARING LACTONE OR SUCCINIC ANHYDRIDE USING CATALYST
The present invention relates to a transition metal-based heterogeneous carbonylation reaction catalyst that has an excellent catalytic activity and selectivity in the carbonylation reaction and is easily separated from a product, by crosslinking polymerizing a transition metal-based homogeneous catalyst unit through a Friedel-Craft reaction; and a method for preparing lactone using the same. The transition metal-based heterogeneous carbonylation reaction catalyst allows to produce lactone or succinic anhydride with an epoxide compound while showing a high selectivity, and can be applied in industrial very usefully due to easy separation from the product and thus reusing thereof.
Method for producing ethylene oxide
According to the present invention, there is provided means for suppressing the occurrence of corrosion on the inner tube side in a heat exchanger and enabling continuous production for a long time period in a process for producing ethylene oxide. An embodiment of the present invention relates to a method for producing ethylene oxide, the method including: supplying a raw material gas including ethylene, molecular oxygen, and a chlorine compound to an ethylene oxidation reactor; subjecting ethylene and molecular oxygen in the raw material gas to catalytic vapor phase oxidation in the ethylene oxidation reactor in the presence of a silver catalyst, and thereby producing a gas including ethylene oxide, water, and a chlorine compound; and cooling a gas to be cooled including water and the chlorine compound using a heat exchanger. According to this method, in the heat exchanger, the gas to be cooled including water to be cooled and a chlorine compound is cooled at a linear gas velocity on the heat exchanger inner tube side of 7 m/s or higher.
Method for producing ethylene oxide
According to the present invention, there is provided means for suppressing the occurrence of corrosion on the inner tube side in a heat exchanger and enabling continuous production for a long time period in a process for producing ethylene oxide. An embodiment of the present invention relates to a method for producing ethylene oxide, the method including: supplying a raw material gas including ethylene, molecular oxygen, and a chlorine compound to an ethylene oxidation reactor; subjecting ethylene and molecular oxygen in the raw material gas to catalytic vapor phase oxidation in the ethylene oxidation reactor in the presence of a silver catalyst, and thereby producing a gas including ethylene oxide, water, and a chlorine compound; and cooling a gas to be cooled including water and the chlorine compound using a heat exchanger. According to this method, in the heat exchanger, the gas to be cooled including water to be cooled and a chlorine compound is cooled at a linear gas velocity on the heat exchanger inner tube side of 7 m/s or higher.
Modulators of liver receptor homologue 1 (LRH-1) and uses
This disclosure relates to modulators of liver receptor homologue 1 (LRH-1) and methods of managing disease and conditions related thereto. In certain embodiments, modulators are derivatives of hexahydropentalene. In certain embodiments, this disclosure relates to methods of treating or preventing cancer, diabetes, or cardiovascular disease by administering an effective amount of a hexahydropentalene derivative disclosed herein.
Methods and apparatuses for purifying crude propane
Systems and methods for purifying crude propane streams are provided herein. For example, in some embodiments, methods are provided including passing a crude propane stream to a fixed bed reactor containing a Beta zeolite configured to reduce the propylene oxide content of the crude propane stream and produce a propylene-treated stream and contacting the propylene-treated stream with an acetaldehyde scavenger to produce a treated propane stream. In some embodiments, methods are provided including passing a crude propane stream through a water wash system to provide a treated propane stream having a lower propylene oxide content, a lower acetaldehyde content, or both.
BETA ZEOLITE, METHOD FOR PRODUCING SAME, AND CATALYST
Provided is a beta zeolite also having exceptional catalytic activity as a catalyst other than an olefin epoxidation catalyst. This beta zeolite is synthesized without using an organic structure-directing agent and has titanium in the structural skeleton thereof, the Ti content being 0.10 mmol/g or higher. This beta zeolite preferably has an Si/Ti molar ratio of 20-200. Also, the Si/Al molar ratio is preferably 100 or higher.